Food & Health

Roche's Enicepatide Boosts Competitiveness

Roche's Enicepatide triumphs in trials, affecting deal terms and valuations against GLP-1 leaders.

September 22, 20263 min read

Sector Watch

Technology

Investor talks hint at $1.2T valuation, raising stakes in AI's market impact.

Sep 163 min read

Food & Health

Pfizer targets air-traffic fees to reclaim $2B, spotlighting contract risks and sector implications.

Sep 143 min read

Technology

Anthropic secures back-to-back profits, hinting at promising deal terms and valuation impacts in AI.

Sep 143 min read

Finance

Berlin insists on job security and Frankfurt listing as UniCredit nears Commerzbank deal, reshaping valuations and sector dynamics.

Sep 113 min read

Food & Health

Roche's Enicepatide triumphs in trials, affecting deal terms and valuations against GLP-1 leaders.

Sep 223 min read

Technology

China's rocket push threatens U.S. firms' margins, reshaping global launch economics. Track the sector's competitive dynamics now.

Sep 213 min read

Energy

Halfway through a $12B spend, TotalEnergies' Suriname output remains set for 2028, impacting sector valuation and deal terms.

Sep 213 min read

Finance

Qantas labor strike pressures freight revenues, heightening investor focus on cost management amid profit margin concerns.

Sep 214 min read